Approval · Notice of Compliance 25575 · 2021
METFORMIN TABLETS: Notice of Compliance 25575
Issued March 31, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25575
- Date
- March 31, 2021
- Company
- Granules India LimitedHyderabad, Telangana, India
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- GLUCOPHAGE (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METFORMIN TABLETS | 02514486 | Marketed |
| METFORMIN TABLETS | 02514494 | Marketed |
Medicinal ingredients
- METFORMIN HYDROCHLORIDE 500 MG per TAB
- METFORMIN HYDROCHLORIDE 850 MG per TAB